Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activityCATHERINO, W. H; JORDAN, V. C.Journal of steroid biochemistry and molecular biology. 1995, Vol 55, Num 2, pp 239-246, issn 0960-0760Article

A risk-benefit assessment of tamoxifen therapyCATHERINO, W. H; JORDAN, V. C.Drug safety. 1993, Vol 8, Num 5, pp 381-397, issn 0114-5916Article

Increasing the number of tandem estrogen response elements increases the estrogenic activity of a tamoxifen analogueCATHERINO, W. H; JORDAN, V. C.Cancer letters. 1995, Vol 92, Num 1, pp 39-47, issn 0304-3835Article

Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanismCATHERINO, W. H; JENG, M. H; JORDAN, V. C et al.British journal of cancer. 1993, Vol 67, Num 5, pp 945-952, issn 0007-0920Article

Estrogenic activity is increased for an antiestrogen by a natural mutation of the estrogen receptorLEVENSON, A. S; CATHERINO, W. H; JORDAN, V. C et al.Journal of steroid biochemistry and molecular biology. 1997, Vol 60, Num 5-6, pp 261-268, issn 0960-0760Article

The biological action of cDNAs from mutated estrogen receptors transfected into breast cancer cellsCATHERINO, W. H; JORDAN, V. C.Cancer letters. 1995, Vol 90, Num 1, pp 35-42, issn 0304-3835Conference Paper

The presence of blood in the transfer catheter negatively influences outcome at embryo transferALVERO, R; HEARNS-STOKES, R. M; CATHERINO, W. H et al.Human reproduction (Oxford. Print). 2003, Vol 18, Num 9, pp 1848-1852, issn 0268-1161, 5 p.Article

The estrogenic activity of synthetic progestins used in oral contraceptivesJORDAN, V. C; JENG, M. H; CATHERINO, W. H et al.Cancer. 1993, Vol 71, Num 4, pp 1501-1505, issn 0008-543X, SUPConference Paper